Ranimizumab (Lucentis) Product Safety Information

Published on medhub.novartis.com.ph (https://www.medhub.novartis.com.ph)

Ranimizumab (Lucentis) Product Safety Information [1]

The following product safety information are essential to ensure the safe and effective use of Ranimizumab (Lucentis).

Ranimizumab (Lucentis) Product Safety Information - Diabetic Macular Edema (DME)

Download the PDF here >> [2]

Ranimizumab (Lucentis) Product Safety Information - Neovascular (Wet) Age-Related Macular Degeneration (wAMD)

Download the PDF here >> [3]

Ranimizumab (Lucentis) Product Safety Information - Retinal Vein Occlusion (RVO)

Download the PDF here>> [4]

Ranimizumab (Lucentis) Product Safety Information - Proliferative Diabetic Retinopathy (PDR)

Download the PDF here>> [5]

Ranimizumab (Lucentis) Product Safety Information - Choroidal Neovascularization (CNV)

Download the PDF here>> [6]

Ranimizumab (Lucentis) Product Safety Information - Retinopathy of Prematurity (ROP)

Download the PDF here>> [7]

Do you find this content useful?:

Source URL:https://www.medhub.novartis.com.ph/services/rmp-materials/ranimizumab-lucentis-product-safety-information

Links
[1] https://www.medhub.novartis.com.ph/services/rmp-materials/ranimizumab-lucentis-product-safety-information [2] https://www.medhub.novartis.com.ph/system/files/Lucentis_%20Diabetic%20Macular%20Edema%20%28DME%29_V16.2.pdf [3] https://www.medhub.novartis.com.ph/system/files/Lucentis_%20Neovascular%20%28Wet%29%20Age-Related%20Macular%20Degeneration%20%28wAMD%29_V20.pdf [4] https://www.medhub.novartis.com.ph/system/files/Lucentis_%20Retinal%20Vein%20Occlusion%20%28RVO%29_V16.2.pdf [5] https://www.medhub.novartis.com.ph/system/files/Lucentis_%20Proliferative%20Diabetic%20Retinopathy%20%28PDR%29_V20.pdf [6] https://www.medhub.novartis.com.ph/system/files/Lucentis_%20Choroidal%20Neovascularization%20%28CNV%29_V16.2.pdf [7] https://www.medhub.novartis.com.ph/sites/medhub.novartis.com.ph/files/Lucentis_%20Retinopathy%20of%20prematurity%20%28ROP%29_V1.pdf